Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments
Benzingaยท2025-09-15 15:29Monte Rosa Therapeutics Inc. GLUE stock is surging on Monday, with a session volume of 11.67 million compared to the average volume of 408.08 thousand as per data from Benzinga Pro.Monte Rosa announced a collaboration with Novartis AG NVS to develop novel degraders for immune-mediated diseases.Under the terms of the agreement, Monte Rosa will receive an upfront payment of $120 million. Monte Rosa will also receive payments to maintain the options.In total deal value, Monte Rosa is eligible to receive up to ...